Security Snapshot

SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) Institutional Ownership

CUSIP: 81619Q105

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

267

Shares (Excl. Options)

100,363,471

Price

$14.85

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
SEM on NYSE
Shares outstanding
124,126,404
Price per share
$16.29
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
100,363,471
Total reported value
$1,490,463,811
% of total 13F portfolios
0%
Share change
-389,479
Value change
-$1,102,465
Number of holders
267
Price from insider filings
$16.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • SEM - SELECT MEDICAL HOLDINGS CORP - Common Stock is tracked under CUSIP 81619Q105.
  • 267 institutions reported positions in Q4 2025.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 267 to 77 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,490,463,811 to $122,753,478.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 267 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 81619Q105?
CUSIP 81619Q105 identifies SEM - SELECT MEDICAL HOLDINGS CORP - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% -19% $294,839,445 -$72,613,311 16,015,179 -20% BlackRock, Inc. 31 Mar 2025
ORTENZIO ROBERT A 11% 0% $209,595,038 14,019,735 0% ORTENZIO ROBERT A 02 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.4% $110,200,042 6,764,889 Vanguard Portfolio Management 31 Mar 2026
ORTENZIO ROCCO A 3.2% $75,214,976 4,085,550 Estate of Rocco A. Ortenzio 31 Dec 2024
PRICE T ROWE ASSOCIATES INC /MD/ 0.1% $2,690,196 165,144 T. Rowe Price Associates, Inc. 31 Mar 2026

As of 31 Dec 2025, 267 institutional investors reported holding 100,363,471 shares of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM). This represents 81% of the company’s total 124,126,404 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) together control 68% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 18,703,734 -2.3% 0% $277,750,448
PRICE T ROWE ASSOCIATES INC /MD/ 13% 16,606,269 +4.3% 0.03% $246,604,000
VANGUARD GROUP INC 10% 12,477,780 -0.75% 0% $185,295,034
DIMENSIONAL FUND ADVISORS LP 4.3% 5,333,595 +2.6% 0.02% $79,204,582
STATE STREET CORP 3.5% 4,397,112 +0.2% 0% $65,297,113
GEODE CAPITAL MANAGEMENT, LLC 2.5% 3,117,638 +0.05% 0% $46,303,912
T. Rowe Price Investment Management, Inc. 2.3% 2,826,987 -1.1% 0.03% $41,981,000
D. E. Shaw & Co., Inc. 1.8% 2,211,898 +19% 0.02% $32,846,685
Western Standard LLC 1.7% 2,064,021 +96% 14% $30,650,712
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 1,686,737 +1.4% 0% $25,048,044
Woodline Partners LP 1.1% 1,340,197 +140% 0.08% $19,901,925
BANK OF AMERICA CORP /DE/ 1% 1,298,453 -22% 0% $19,282,026
NORTHERN TRUST CORP 1% 1,293,749 -4.4% 0% $19,212,173
Hood River Capital Management LLC 1% 1,266,887 -17% 0.21% $18,813,272
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.95% 1,185,399 0.03% $17,603,175
Bank of New York Mellon Corp 0.86% 1,062,284 -16% 0% $15,774,914
Prosight Management, LP 0.83% 1,035,086 +18% 3.2% $15,371,027
Invesco Ltd. 0.82% 1,022,061 -33% 0% $15,177,606
MORGAN STANLEY 0.78% 966,710 -21% 0% $14,355,665
ALGERT GLOBAL LLC 0.75% 927,397 +997% 0.21% $13,772,000
Eversept Partners, LP 0.73% 906,100 0.75% $13,455,585
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.64% 788,380 +7.1% 0.25% $11,707,443
Dana Investment Advisors, Inc. 0.55% 678,545 +29% 0.29% $10,076,393
Cambria Investment Management, L.P. 0.45% 557,494 0.48% $8,278,786
MILLENNIUM MANAGEMENT LLC 0.44% 548,153 -66% 0.01% $8,140,072

Institutional Holders of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 7,536,159 $122,753,478 +$31,730,243 $16.29 77
2025 Q4 100,363,471 $1,490,463,811 -$1,102,465 $14.85 267
2025 Q3 100,630,018 $1,292,290,678 -$3,943,549 $12.84 264
2025 Q2 100,467,489 $1,525,083,959 -$89,875,058 $15.18 261
2025 Q1 106,587,834 $1,780,162,120 +$14,970,670 $16.70 272
2024 Q4 105,388,891 $1,986,844,341 +$42,067,914 $18.85 269
2024 Q3 99,334,828 $3,463,519,440 -$26,081,324 $34.87 282
2024 Q2 99,618,759 $3,492,995,625 +$18,268,271 $35.06 256
2024 Q1 99,503,977 $3,006,124,893 +$69,182,933 $30.15 250
2023 Q4 98,119,502 $2,306,204,585 +$18,779,961 $23.50 244
2023 Q3 97,233,591 $2,456,859,968 -$48,424,716 $25.27 245
2023 Q2 99,025,471 $3,154,155,784 -$116,781,236 $31.86 222
2023 Q1 102,689,349 $2,654,415,315 +$18,749,371 $25.85 212
2022 Q4 102,397,663 $2,542,784,716 +$25,549,153 $24.83 208
2022 Q3 101,488,474 $2,243,068,480 -$120,566,916 $22.10 206
2022 Q2 100,041,374 $2,363,545,334 -$68,482,910 $23.62 200
2022 Q1 103,694,537 $2,489,447,256 -$2,180,923 $23.99 226
2021 Q4 103,029,624 $3,030,122,771 -$40,766,909 $29.40 232
2021 Q3 103,646,590 $3,748,783,650 -$51,370,789 $36.17 241
2021 Q2 104,705,394 $4,424,067,823 +$58,675,339 $42.26 260
2021 Q1 103,635,773 $3,534,318,747 +$28,753,506 $34.10 250
2020 Q4 102,783,972 $2,843,553,415 +$31,305,197 $27.66 203
2020 Q3 101,854,148 $2,120,291,076 -$5,114,389 $20.82 187
2020 Q2 102,176,554 $1,504,986,527 -$14,643,588 $14.73 197
2020 Q1 103,342,430 $1,550,138,999 -$5,713,641 $15.00 207
2019 Q4 102,603,806 $2,394,699,156 -$3,309,945 $23.34 213
2019 Q3 103,339,735 $1,712,428,525 -$9,416,499 $16.57 180
2019 Q2 103,991,486 $1,650,257,879 +$14,435,361 $15.87 188
2019 Q1 104,036,299 $1,465,920,146 -$21,951,024 $14.09 197
2018 Q4 105,066,432 $1,613,226,001 -$2,892,006 $15.35 202
2018 Q3 104,383,799 $1,920,408,122 +$22,432,858 $18.40 191
2018 Q2 103,232,178 $1,873,755,098 +$6,252,776 $18.15 190
2018 Q1 102,763,926 $1,772,906,931 +$1,689,508 $17.25 194
2017 Q4 102,480,572 $1,808,697,106 +$28,386,455 $17.65 178
2017 Q3 105,162,450 $2,018,821,900 +$7,381,164 $19.20 177
2017 Q2 105,813,842 $1,624,436,801 -$18,998,054 $15.35 149
2017 Q1 107,529,085 $1,435,554,303 +$133,483,992 $13.35 159
2016 Q4 110,471,459 $1,463,987,011 +$7,750,907 $13.25 152
2016 Q3 109,766,739 $1,481,466,612 +$30,598,399 $13.50 155
2016 Q2 107,294,445 $1,167,964,833 +$3,106,468 $10.87 167
2016 Q1 106,595,310 $1,262,176,086 -$8,566,808 $11.81 151
2015 Q4 107,271,735 $1,277,369,361 +$35,144,464 $11.91 159
2015 Q3 105,982,997 $1,143,728,353 -$20,405,478 $10.79 162
2015 Q2 106,636,790 $1,727,518,825 +$65,949,546 $16.20 179
2015 Q1 102,245,360 $1,515,955,158 +$52,705,677 $14.83 157
2014 Q4 98,819,897 $1,423,070,595 +$50,487,952 $14.40 158
2014 Q3 95,610,561 $1,150,194,086 +$43,556,315 $12.03 166
2014 Q2 91,517,707 $1,426,323,254 +$114,157,897 $15.60 163
2014 Q1 84,700,960 $1,054,506,209 +$183,342,183 $12.45 140
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .